AI MARKET SCANNING

Matinas BioPharma Holdings Inc

AVG HISTORICAL GAP -5.82%
MAX GAP RECORD -32.73%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $MTNB
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Aug 12, 2026 Earnings Release 2026-08-12 (UNDETERMINED)
+0.00%
Aug 13, 2025 Earnings Release 2025-08-13 (AFTER CLOSE)
-1.28%
Apr 15, 2025 Earnings Release 2025-04-15 (AFTER CLOSE)
-1.72%
Nov 13, 2024 Earnings Release 2024-11-13 (AFTER CLOSE)
-5.21%
Aug 14, 2024 Earnings Release 2024-08-14 (AFTER CLOSE)
+0.64%
May 10, 2024 Earnings Release 2024-05-10 (AFTER CLOSE)
+1.14%
Nov 08, 2023 Earnings Release 2023-11-08 (AFTER CLOSE)
+1.09%
Aug 09, 2023 Earnings Release 2023-08-09 (AFTER CLOSE)
-32.73%

VOLATILITY & GAP BIAS

AVG GAP MOVE 7.6%
Bullish Gaps (3)
Bearish Gaps (5)
Neutral / Flat (1)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $MTNB

EXECUTIONS0 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
Radar monitoring: awaiting next setup.
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗